Syros Pharmaceuticals, Inc. - COM NEW (SYRS)

Historical Portfolio Holders from Q3 2022 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
20.4M
Holdings value Q2 2024
$105M
Value change Q2 2024
-$2.84M
Grand Portfolio weight change Q2 2024
0%
Number of holders
70
Number of buys Q2 2024
30
Number of sells Q2 2024
-27
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 10K $21.5K +$21.5K $2.15 1
2024 Q2 20.4M $105M -$2.84M $5.16 70
2024 Q1 20.9M $112M +$14.6M $5.35 76
2023 Q4 17.8M $138M +$54M $7.79 58
2023 Q3 12.1M $47.9M +$6.04M $3.95 48
2023 Q2 10.6M $33.5M +$1.18M $3.15 53
2023 Q1 10.3M $27.5M -$1.43M $2.67 53
2022 Q4 10.6M $37.9M +$7.58M $3.59 51
2022 Q3 8.43M $54.3M +$54.3M $6.44 42